• Mutation; HGNC; 9811; RAD21; Simple; p.Tyr3Ter (c.9C>G); Zygosity=Unspecified (PubMed=23955599).
  

PubMed=9852262; DOI=10.3892/ijmm.1.3.559
Miura N., Sato T., Fuse A., Okimoto Y., Kinugawa N., Horie H., Ota S., Kakuda H., Yokoe H., Miya T., Suzuki N., Niimi H.
Establishment of a new human megakaryoblastic cell line, CMY, with chromosome 17p abnormalities.
Int. J. Mol. Med. 1:559-563(1998)

PubMed=10674912; DOI=10.3109/10428190009148861
Sato T., Sekine H., Kakuda H., Miura N., Sunohara M., Fuse A.
HIV infection of megakaryocytic cell lines.
Leuk. Lymphoma 36:397-404(2000)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)

PubMed=14504097; DOI=10.1182/blood-2003-02-0418
Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R., Tsuchida M., Sugita K., Ida K., Hayashi Y.
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.
Blood 103:1085-1088(2004)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=23955599; DOI=10.1038/ng.2731
Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y., Yoshida K.-i., Okuno Y., Bando M., Nakato R., Ishikawa S., Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D., Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K., Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M., Nakamaki T., Ishiyama K., Nolte F., Hofmann W.-K., Miyawaki S., Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H., Haferlach T., Shirahige K., Miyano S., Ogawa S.
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Nat. Genet. 45:1232-1237(2013)